- Home
- / HUYA Bioscience International
HUYA Bioscience International
Total Funding
$12.6 M
HUYA Bioscience International Summary
Company Summary
- Overview
- HUYA Bioscience International is a company specializing in the biopharmaceutical products. It provides a number of compounds including the oncology drug HBI-8000, the anti-arrhythmic HBI-3000, and the small molecule with regenerative properties for myocardial infarction HBI-3802.
- Type
- Private
- Status
- Active
- Founded
- 2004
- HQ
- San Diego, CA, US | view all locations
- Website
- https://www.huyabio.com/
- Cybersecurity rating
Table of Contents
Key People
Hiroshi Onogi, Executive Vice President, Head of Clinical Development, Japan
Gloria Lee, Chief Medical Officer
Curtis Tyree, Senior Vice President, Strategic Planning
LocationsView all
12 locations detected
San Diego, CA HQ
United States
12531 High Bluff Dr #138
Chengdu Shi
China
Guangzhou Shi, Guangdong Sheng
China
room 204, building 23, 110-1 Xianlie Middle Rd, Yuexiu Qu
Hangzhou, Zhejiang
China
Xiasha District, Jianggan District
Shenzhen Shi, Guangdong Sheng
China
Shenzhen Shi, Guangdong Sheng
China
Hi-Tech Park station, Shenzhen Software Park (Gaoxin South 7th Road), Nanshan Qu